...
首页> 外文期刊>Journal of thrombosis and thrombolysis >Determinants of intracranial hemorrhage incidence in patients on oral anticoagulation followed at the Lahey clinic.
【24h】

Determinants of intracranial hemorrhage incidence in patients on oral anticoagulation followed at the Lahey clinic.

机译:在Lahey诊所接受口服抗凝治疗的患者颅内出血发生率的决定因素。

获取原文
获取原文并翻译 | 示例
           

摘要

Oral anticoagulation with warfarin is widely used to treat venous and arterial thromboembolic disease (Ansell et al. Chest 133(6 suppl):160S-198S, 2008). Its administration is associated with a risk of intracranial hemorrhage (ICH), a devastating complication which usually results in death or severe disability (Fang et al. Am J Med,120(8):700-705, 2007; Rosand et al. Arch Intern Med, 164(8):880-884, 2004). The international normalized ratio (INR) is one of the factors which can help determine the risk of ICH in a given individual (Singer et al. Circ Cardiovasc Qual Outcomes, 2(4):297-304, 2009). Using the DoseResponse((R)) patient database at our institution, we carried a retrospective nested matched case-control study to identify patient characteristics associated with the occurrence of ICH. The database was queried for the years 2004-2009. Each case was matched by month to four control patients having a routine INR determination for the monitoring of chronic anticoagulation. The following characteristics were captured: bleeding type, INR, age, sex, blood pressure, hemoglobin, creatinine, presence or history of pertinent comorbid conditions, intake of antiplatelet agents (aspirin or thienopyridine) and indication for anticoagulation. The relationship between those risk factors and the odds ratio of ICH was determined with conditional logistic regression. Fifty cases of ICH were retrieved. When correcting for pertinent variables, the odds ratio of ICH increased significantly for higher INR values, with a quadratic relationship noted in the model. Increasing mean blood pressure seemed to be associated with a higher risk of ICH, also in an exponential manner. Rising hemoglobin values on the other hand seemed to have a protective effect against such events. About 50% of cases of ICH occurred in or below the therapeutic INR range. The intake of antiplatelet agent was found to be associated with ICH in univariate analysis only. The INR is an important predictor for the incidence of ICH, but in this study an elevated measurement was found in only half of cases. Mean blood pressure appears to be another important determinant of the risk of ICH in the anticoagulated patient population.
机译:华法林的口服抗凝剂被广泛用于治疗静脉和动脉血栓栓塞性疾病(Ansell等,Chest 133(6 suppl):160S-198S,2008)。它的给药与颅内出血(ICH)的风险有关,颅内出血是一种破坏性并发症,通常会导致死亡或严重残疾(Fang等人,Am J Med,120(8):700-705,2007; Rosand等人,Arch Intern Med,164(8):880-884,2004)。国际标准化比率(INR)是可以帮助确定给定个体中ICH风险的因素之一(Singer等人Circ Cardiovasc Qual Outcomes,2(4):297-304,2009)。使用我们机构的DoseResponse(R)患者数据库,我们进行了一项回顾性嵌套匹配病例对照研究,以鉴定与ICH发生相关的患者特征。查询了2004-2009年的数据库。每例病例均按月与四名对照患者进行配对,这些患者具有常规INR监测,以监测慢性抗凝作用。捕获了以下特征:出血类型,INR,年龄,性别,血压,血红蛋白,肌酐,相关合并症的存在或病史,抗血小板药物(阿司匹林或噻吩并吡啶)的摄入以及抗凝的指征。通过条件逻辑回归确定这些危险因素与ICH比值比之间的关系。检索到50例ICH。校正相关变量时,对于较高的INR值,ICH的优势比显着增加,并且模型中记录了二次关系。平均血压的升高似乎也与ICH的高风险有关,而且也呈指数关系。另一方面,血红蛋白值的升高似乎对此类事件具有保护作用。约50%的ICH病例发生在治疗性INR范围内或以下。仅在单变量分析中发现抗血小板药的摄入与ICH有关。 INR是ICH发病率的重要预测指标,但在本研究中,仅一半病例发现INR升高。平均血压似乎是抗凝患者人群中ICH风险的另一个重要决定因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号